P
Phlo
Digital pharmacy platform for prescription delivery and healthcare
About Phlo
Phlo is a digital healthcare company that provides a suite of services centered around pharmacy and patient care. Founded in 2015 by Nadeem Sarwar, the Glasgow-based startup aims to simplify medication access. Sarwar, who previously worked in commercial banking with exposure to the pharmacy sector, was inspired by customer-centric digital health models in the U.S. to build a more convenient pharmacy experience in the UK.
The company's core services include Phlo Digital Pharmacy, an app-based service for managing and ordering NHS and private prescriptions with same-day delivery in cities like London and tracked next-day delivery across the UK. Phlo also operates Phlo Clinic, which offers on-demand consultations and treatments for various conditions, including weight management. For business clients, Phlo Connect provides an API-driven infrastructure platform that allows other healthcare providers to integrate pharmacy services, including prescribing, fulfillment, and delivery, directly into their own offerings. The company generates revenue through its pharmacy services and by providing its technology platform to other healthcare businesses.
Phlo has expanded through significant funding rounds, including a £10m Series A raise and a subsequent £9m investment in April 2024, led by Par Equity, Thairm Bio, and Scottish Enterprise. A key milestone was the acquisition of the UK assets of its competitor, TruePill, in March 2023, solidifying its market position. The company emphasizes a patient-centric approach, combining technology with accessible support from its team of pharmacists via phone, email, and live chat.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2015
- Headquarters
- Glasgow, United Kingdom
- Employees
- 117
- Open positions
- 6
- Dealroom signal
- 89.3/100
- Industry
- Health
- Sub-industry
- Pharmaceutical, Health Platform, Logistics & Delivery
- Sector
- Biotech & Life Sciences, Pharmacy, Biotechnology, Biotech and Pharma, Digital Care, Health It, Digital Pharma
- Technology
- Mobile app
- Business model
- Marketplace & ecommerce
- Client focus
- b2b, b2c
Knowledge graph
More headlines
Open roles
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| EARLY VC✓Equity / VC | Apr 2024 | $12M | $66M | Scottish Enterprise Growth Investments · Thairm Bio Family Office · Par Equity | ↗ |
| SERIES A✓Equity / VC | Feb 2023 | $13M | $53M | Thairm Bio Family Office | ↗ |
Growth signals
Latest recorded traffic for Phlo is 45K monthly website visits, up 66.7% over the last three months. Phlo's team grew 18.2% over the past year.
Open positions
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed1 investor entered at this stage
Series A3 investors entered at this stage
- TOThairm Bio Family Office
Par Equity
Scottish Enterprise Growth Investments
Other known investors3 additional known investors
PXN Group
Techscaler
World Solver Syndicate
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Phlo on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Phlo’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.








